Tianjin Pharmaceutical Da Ren Tang Group Corporation Market Cap

Tianjin Pharmaceutical Da Ren Tang Group Corporation has a market cap or net worth of 20.24 billion as of January 3, 2025. Its market cap has decreased by -11.78% in one year.

Market Cap

20.24B

Enterprise Value

20.06B

Revenue

8.04B

Ranking

n/a

PE Ratio

24.95

Stock Price

30.54

Market Cap Chart

Since June 6, 2001, Tianjin Pharmaceutical Da Ren Tang Group Corporation's market cap has increased from 6.92B to 20.24B, an increase of 192.65%. That is a compound annual growth rate of 4.66%.

Market Cap History

Date	Market Cap	% Change
Jan 3, 2025	20.24B	-2.23%
Dec 31, 2024	20.70B	-6.43%
Dec 29, 2023	22.12B	21.24%
Dec 30, 2022	18.25B	-6.30%
Dec 31, 2021	19.47B	73.88%
Dec 31, 2020	11.20B	23.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Shenzhen Mindray Bio-Medical Electronics	299.75B
Jiangsu Hengrui Medicine	285.82B
WuXi AppTec	152.03B
Zhangzhou Pientzehuang Pharmaceutical.,	126.13B
Aier Eye Hospital Group	118.26B
Yunnan Baiyao Group Co.,Ltd	103.58B
Shanghai United Imaging Healthcare	103.27B
Beijing Wantai Biological Pharmacy Enterprise	85.14B

Market Cap Rankings